ATE463571T1 - Unterschiedlich exprimierte gene in bauchspeicheldrüsen-krebs und -dysplasie - Google Patents

Unterschiedlich exprimierte gene in bauchspeicheldrüsen-krebs und -dysplasie

Info

Publication number
ATE463571T1
ATE463571T1 AT99930528T AT99930528T ATE463571T1 AT E463571 T1 ATE463571 T1 AT E463571T1 AT 99930528 T AT99930528 T AT 99930528T AT 99930528 T AT99930528 T AT 99930528T AT E463571 T1 ATE463571 T1 AT E463571T1
Authority
AT
Austria
Prior art keywords
dysplasia
cancer
polynucleotides
regulated
pancreatic cancer
Prior art date
Application number
AT99930528T
Other languages
English (en)
Inventor
Giulia Kennedy
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of ATE463571T1 publication Critical patent/ATE463571T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99930528T 1998-06-23 1999-06-22 Unterschiedlich exprimierte gene in bauchspeicheldrüsen-krebs und -dysplasie ATE463571T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9039198P 1998-06-23 1998-06-23
US11857099P 1999-02-03 1999-02-03
US09/337,171 US6262249B1 (en) 1998-06-23 1999-06-21 Pancreatic cancer genes
PCT/US1999/014036 WO1999067386A2 (en) 1998-06-23 1999-06-22 Differentially expressed genes in pancreatic cancer and displasia

Publications (1)

Publication Number Publication Date
ATE463571T1 true ATE463571T1 (de) 2010-04-15

Family

ID=27376554

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99930528T ATE463571T1 (de) 1998-06-23 1999-06-22 Unterschiedlich exprimierte gene in bauchspeicheldrüsen-krebs und -dysplasie

Country Status (7)

Country Link
US (21) US6262249B1 (de)
EP (1) EP1090117B1 (de)
AT (1) ATE463571T1 (de)
AU (1) AU4705199A (de)
DE (1) DE69942226D1 (de)
ES (1) ES2344179T3 (de)
WO (1) WO1999067386A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262249B1 (en) * 1998-06-23 2001-07-17 Chiron Corporation Pancreatic cancer genes
WO2001055301A2 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
AU2001279103A1 (en) * 2000-08-03 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of pancreatic cancer
US20020076721A1 (en) * 2000-08-07 2002-06-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of pancreatic cancer
CA2420983A1 (en) * 2000-09-05 2002-05-23 Incyte Genomics, Inc. Molecules for disease detection and treatment
WO2002060317A2 (en) * 2001-01-30 2002-08-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of pancreatic cancer
JP4679149B2 (ja) 2002-09-30 2011-04-27 オンコセラピー・サイエンス株式会社 ヒト膵癌に関連する遺伝子およびポリペプチド
AU2003900747A0 (en) * 2003-02-18 2003-03-06 Garvan Institute Of Medical Research Diagnosis and treatment of pancreatic cancer
WO2004092407A1 (en) * 2003-04-17 2004-10-28 Genesis Group Inc. Pygopus in diagnosis and treatment of cancer
GB0320877D0 (en) * 2003-09-05 2003-10-08 Celltech R&D Ltd A protein involved in carcinoma
GB0329997D0 (en) * 2003-12-24 2004-01-28 Cancer Rec Tech Ltd Methods for detecting neoplasia and markers thereof
EP2402758B1 (de) * 2005-09-19 2014-09-10 Janssen Diagnostics, LLC Verfahren und Verwendungen zum Identifizieren des Ursprungs eines Karzinoms mit unbekanntem primären Ursprung
MX2010003371A (es) 2007-09-28 2010-05-05 Intrexon Corp Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571146B1 (fr) 1984-10-01 1988-02-26 Centre Nat Rech Scient Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
US5185254A (en) 1988-12-29 1993-02-09 The Wistar Institute Gene family of tumor-associated antigens
WO1991008217A1 (en) * 1989-12-05 1991-06-13 The Regents Of The University Of California Human intestinal mucins
US5532135A (en) * 1990-02-02 1996-07-02 Cancer Research Fund Of Contra Costa Solid-phase competitive assay utilizing a fusion protein
US5645994A (en) * 1990-07-05 1997-07-08 University Of Utah Research Foundation Method and compositions for identification of species in a sample using type II topoisomerase sequences
DK72593D0 (da) 1993-06-18 1993-06-18 Symbicom Ab Rekombinant protein
US5990299A (en) * 1995-08-14 1999-11-23 Icn Pharmaceuticals, Inc. Control of CD44 gene expression for therapeutic use
WO1998002560A2 (en) 1996-07-12 1998-01-22 Institute Of Molecular Biotechnology Genomic sequence of rhizobium sp. ngr 234 symbiotic plasmid
US6720413B1 (en) * 1997-03-04 2004-04-13 Musc Foundation For Research Development Methods and compositions for diagnosis and treatment of cancer
EP1003880A2 (de) * 1997-06-05 2000-05-31 Incyte Pharmaceuticals, Inc. Menschliches ubiquitin trägerprotein-ähnliches protein und cyclin b-ähnliches protein
EP0996857B1 (de) * 1997-07-17 2009-09-09 Ludwig Institute For Cancer Research Krebsassoziierte nukleinsäure und proteine
CA2298451A1 (en) * 1997-08-06 1999-02-18 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
AU9127098A (en) 1997-09-04 1999-03-22 Osiris Therapeutics, Inc. Ligands that modulate differentiation of mesenchymal stem cells
EP1019506A4 (de) * 1997-10-02 2003-04-09 Human Genome Sciences Inc 101 sekretierte proteine vom menschen.
US6262249B1 (en) 1998-06-23 2001-07-17 Chiron Corporation Pancreatic cancer genes
US6610906B1 (en) * 1999-06-09 2003-08-26 The Regents Of The University Of Michigan Nucleotide sequences for gene regulation and methods of use thereof
EP1268856A2 (de) * 2000-04-07 2003-01-02 Epigenomics AG Detektion von snp's und cytosin-methylierungen

Also Published As

Publication number Publication date
US20090275054A1 (en) 2009-11-05
US7666992B2 (en) 2010-02-23
WO1999067386A2 (en) 1999-12-29
US20090142350A1 (en) 2009-06-04
US20090270483A1 (en) 2009-10-29
DE69942226D1 (de) 2010-05-20
US6664054B2 (en) 2003-12-16
US20090275019A1 (en) 2009-11-05
ES2344179T3 (es) 2010-08-19
US20090269347A1 (en) 2009-10-29
US20090275069A1 (en) 2009-11-05
US20090275734A1 (en) 2009-11-05
US6262249B1 (en) 2001-07-17
EP1090117B1 (de) 2010-04-07
US8460873B2 (en) 2013-06-11
AU4705199A (en) 2000-01-10
US20010016651A1 (en) 2001-08-23
US7863423B2 (en) 2011-01-04
US20090269348A1 (en) 2009-10-29
US20080274111A1 (en) 2008-11-06
US20090269740A1 (en) 2009-10-29
US20090156522A1 (en) 2009-06-18
US8030455B2 (en) 2011-10-04
WO1999067386A3 (en) 2000-06-15
US20090226995A1 (en) 2009-09-10
US20090148922A1 (en) 2009-06-11
EP1090117A2 (de) 2001-04-11
US20090275101A1 (en) 2009-11-05
US20120020977A1 (en) 2012-01-26
US7541142B2 (en) 2009-06-02
US20080194480A1 (en) 2008-08-14
US20090142746A1 (en) 2009-06-04
US20100324272A1 (en) 2010-12-23
US20030212264A1 (en) 2003-11-13
WO1999067386A8 (en) 2000-07-20

Similar Documents

Publication Publication Date Title
ATE463571T1 (de) Unterschiedlich exprimierte gene in bauchspeicheldrüsen-krebs und -dysplasie
Guldberg et al. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma
ATE310819T1 (de) Säugetieren apoptosis inhibitorprotein genfamilie,primers, probes und verfahren zur nachweis
DK1607402T3 (da) Sammensætninger og fremgangsmåder til tumorbehandling
ATE386804T1 (de) Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
WO1998041648A3 (en) Target genes for allele-specific drugs
BR0316435A (pt) Produtos genéticos expressos diferencialmente em tumores e uso dos mesmos
WO2000053755A3 (en) Compositions and methods for the treatment of tumor
ATE229977T1 (de) Peptide mit antiproliferativen eigenschaften
Ozelius et al. The gene (DYT1) for early-onset torsion dystonia encodes a novel protein related to the Clp protease/heat shock family
ATE444971T1 (de) Zusammensetzungen und verfahren für die tumor- behandlung
AUPP472398A0 (en) Protease susceptibility II
KR100473551B1 (en) Compositions and Methods for The Treatment of Tumor
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
ATE466938T1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
WO2000037640A3 (en) Compositions and methods for the treatment of tumor
ATE313631T1 (de) Dna polymerase lambda und ihre verwendungen
GR3017164T3 (en) Methods and compositions for the treatment of malignancies in which a protein kinase is associated.
DE69632963D1 (de) Mch3, eine apoptosis-protease, kodierende nukleinsäuren und methoden zur verwendung
DE69733491D1 (de) In Krebszellen überexprimiertes Genprodukt
WO2003094844A3 (en) Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms
BR0012301A (pt) Inibidores de crescimento de células epiteliais
ATE213773T1 (de) In apoptosis beteiligte cysteine protease cmh-1 und dns-sequenzen dafür
EP1214942A3 (de) Verwendung von mit Bacteriophagen, die ein tumorspezifisches und/oder tumorassoziliertes Antigen auf ihrer Oberfläche tragen, beladenen dendritischen Zellen zur Behandlung von Tumoren
Ohi et al. Cloning of an Alternative Form of Plakoglobin (γ-Catenin) Lacking the Fourth Armadillo Repeat1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties